
Isomorphic Labs aims for $40B+ valuation in new funding, boosting AI drug discovery race.
Isomorphic Labs, an AI drug discovery startup spun out of Alphabet's DeepMind, is in talks to raise new funding valuing the company at $40 billion to $50 billion. This would be a significant increase from its $2.1 billion Series B round five months a...





